These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 36586590)
21. Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B. Zhang ZQ; Zhang XN; Lu W; Wang YB; Weng QC; Feng YL BMC Gastroenterol; 2017 Dec; 17(1):140. PubMed ID: 29202690 [TBL] [Abstract][Full Text] [Related]
22. Predictive role of early treatment dynamics of HBV RNA and HBcrAg for HBeAg seroconversion in children with chronic hepatitis B. Lai X; OuYang W; Li S; Qiu J; Zhang H; Jiang T; Qin X; Tang L; Gu Y; Yao Z; Peng S J Med Virol; 2024 May; 96(5):e29670. PubMed ID: 38773810 [TBL] [Abstract][Full Text] [Related]
23. High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy. Hume SJ; Wong DK; Yuen MF; Jackson K; Bonanzinga S; Vogrin S; Hall SAL; Burns GS; Desmond PV; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll AJ; Strasser SI; Sievert W; Ngu MC; Sinclair M; Meredith C; Matthews G; Revill PA; Littlejohn M; Bowden S; Visvanathan K; Holmes JA; Thompson AJ Liver Int; 2024 Oct; 44(10):2605-2614. PubMed ID: 39007640 [TBL] [Abstract][Full Text] [Related]
24. Baseline and on-treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals. Hwang SY; Yoo SH; Chang HY; Kim S; Lee JI; Lee KS; Cho YY; Joon KH; Lee HW J Viral Hepat; 2023 Jan; 30(1):39-45. PubMed ID: 36321949 [TBL] [Abstract][Full Text] [Related]
25. Relationship between hepatitis B core-related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analogues. Sonneveld MJ; van Oord GW; van Campenhout MJ; De Man RA; Janssen HLA; de Knegt RJ; Boonstra A; van der Eijk AA J Viral Hepat; 2019 Jul; 26(7):828-834. PubMed ID: 30896057 [TBL] [Abstract][Full Text] [Related]
26. Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis. Zhang ZQ; Wang YB; Lu W; Liu DP; Shi BS; Zhang XN; Huang D; Li XF; Zhou XL; Ding RR Ann Lab Med; 2019 Jan; 39(1):67-75. PubMed ID: 30215232 [TBL] [Abstract][Full Text] [Related]
27. Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in HBeAg-negative and HBsAg-cleared Chronic Hepatitis B Patients. Suzuki T; Matsuura K; Inoue T; Sasada K; Ogawa S; Watanabe T; Kawamura H; Fujiwara K; Kataoka H; Tanaka Y J Med Virol; 2024 Jul; 96(7):e29816. PubMed ID: 39015036 [TBL] [Abstract][Full Text] [Related]
28. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy. Li J; Sun X; Fang J; Wang C; Han G; Ren W Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis B core-related antigen levels predict pegylated interferon-α therapy response in HBeAg-positive chronic hepatitis B. Beudeker BJ; Groothuismink ZM; de Man RA; Janssen H; van der Eijk AA; Boonstra A; Sonneveld MJ Antivir Ther; 2020; 25(4):217-222. PubMed ID: 32744512 [TBL] [Abstract][Full Text] [Related]
30. Use of HBV RNA and to predict change in serological status and disease activity in CHB. Ghany MG; King WC; Hinerman AS; Lok AS; Lisker-Melman M; Chung RT; Terrault N; Janssen HLA; Khalili M; Lee WM; Lau DTY; Cloherty GA; Sterling RK Hepatology; 2023 Nov; 78(5):1542-1557. PubMed ID: 37074026 [TBL] [Abstract][Full Text] [Related]
31. Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy. Liao H; Liu Y; Li X; Wang J; Chen X; Zou J; Li Q; Liu L; Wang J; Huang B; Lu F; Xu D Antivir Ther; 2019; 24(2):105-115. PubMed ID: 30511941 [TBL] [Abstract][Full Text] [Related]
32. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients. Zhang ZQ; Shi BS; Lu W; Liu DP; Huang D; Feng YL Gastroenterol Hepatol; 2020 Nov; 43(9):526-536. PubMed ID: 32921478 [TBL] [Abstract][Full Text] [Related]
33. Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients. García-López M; Lens S; Pallett LJ; Testoni B; Rodríguez-Tajes S; Mariño Z; Bartres C; García-Pras E; Leonel T; Perpiñán E; Lozano JJ; Rodríguez-Frías F; Koutsoudakis G; Zoulim F; Maini MK; Forns X; Pérez-Del-Pulgar S J Hepatol; 2021 May; 74(5):1064-1074. PubMed ID: 33278456 [TBL] [Abstract][Full Text] [Related]
34. Characteristics analysis of hepatitis B core-related antigen in children with hepatitis B e antigen-positive chronic viral hepatitis B infection. Wang FC; Dong Y; Xu ZQ; Gao YJ; Yan JG; Cao LL; Feng DN; Liu C; Zhong YW; Zhang M; Xin SJ Eur J Gastroenterol Hepatol; 2024 Oct; 36(10):1238-1242. PubMed ID: 38973529 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature. Afifi AM; Elgenidy A; Hashim M; Awad AK; Jalal PK Rev Med Virol; 2022 Nov; 32(6):e2353. PubMed ID: 35441759 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy. Erken R; Zaaijer HL; Willemse SB; Bakker E; Takkenberg BB; Reesink HW; Kootstra NA Ann Hepatol; 2021 Dec; 26():100540. PubMed ID: 34583061 [TBL] [Abstract][Full Text] [Related]
37. Characterization of Hepatitis B Precore/Core-Related Antigens. Hong X; Luckenbaugh L; Mendenhall M; Walsh R; Cabuang L; Soppe S; Revill PA; Burdette D; Feierbach B; Delaney W; Hu J J Virol; 2021 Jan; 95(3):. PubMed ID: 33148795 [TBL] [Abstract][Full Text] [Related]
38. PgRNA kinetics predict HBsAg reduction in pregnant chronic hepatitis B carriers after treatment cessation. Wang CR; Liu XQ; Li H; Zhang Q; Zhong GC; Tang Q; Chang Y; Wang JS; Duan YQ; Hu P Front Cell Infect Microbiol; 2022; 12():1055774. PubMed ID: 36579348 [TBL] [Abstract][Full Text] [Related]
39. Serum HBV RNA is associated with liver fibrosis regression in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues. Bian D; Zhao J; Liao H; Wang Y; Ren Y; Jiang Y; Liu S; Chen X; Hu Z; Duan Z; Lu F; Zheng S J Viral Hepat; 2023 Apr; 30(4):303-309. PubMed ID: 36533536 [TBL] [Abstract][Full Text] [Related]
40. Predictive Value of Hepatitis B Core-Related Antigen (HBcrAg) During the Natural History of Hepatitis B Virus Infection. Gou Y; Zhao Y; Rao C; Feng S; Wang T; Li D; Tao C Clin Lab; 2017 Jul; 63(7):1063-1070. PubMed ID: 28792701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]